InsidersTradesSigma
Edesa Biotech, Inc. Stock: price and insider trades · United States · SEC (Form 4)
Track the Edesa Biotech, Inc. stock price and the full management transaction log of the company, a publicly traded company based in United States. Shares are quoted on US US, under the authority of SEC (Form 4). Operating in the Health Care sector, Edesa Biotech, Inc. has logged 65 insider filings. Market capitalisation: €72.2m. The latest transaction was filed on 17 June 2026 (16 - Acquisition or disposition under a prospectus exemption). Among the most active insiders: Nijhawan Pardeep. The full history is accessible without an account.
65
Insider Decl.
0
Thresholds
€124,892
18 ops.
Buy Volume
€331,866
1 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Edesa Biotech, Inc. Strong Buy (bullish), based on 3 analysts. Average price target: US$16.33.
38Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 17 June 2026
Declarations65 total
▲
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives
153,530 shares@ CA$5.210.93% mcap100.0% of flowCommon SharesTSXSEDI:4736614
Ideal exit: 13 Mar 2027 (T+270)
153,550 sharesCommon SharesSEC:0001171843-26-004151:0
64,609 sharesRestricted Share UnitsTSXSEDI:4726433
19,000 sharesRestricted Share UnitsTSXSEDI:4726284
19,000 sharesRestricted Share UnitsTSXSEDI:4726278
19,000 sharesRestricted Share UnitsTSXSEDI:4726250
64,609 sharesRestricted Share UnitsTSXSEDI:4726240
●
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives
14SEDI ↗
96,913 sharesRestricted Share UnitsTSXSEDI:4726235
19,000 sharesRestricted Share UnitsTSXSEDI:4726229
19,000 sharesRestricted Share UnitsTSXSEDI:4726226
19,000 sharesRestricted Share UnitsTSXSEDI:4726223
1,671 shares0Common SharesSEC:0001171843-26-003842:0
64,609 shares0Common SharesSEC:0001171843-26-003801:0
19,000 shares0Common SharesSEC:0001171843-26-003803:0
19,000 shares0Common SharesSEC:0000921895-26-001502:0
96,913 shares0Common SharesSEC:0001171843-26-003797:0
19,000 shares0Common SharesSEC:0001171843-26-003799:0
19,000 shares0Common SharesSEC:0001171843-26-003800:0
64,609 shares0Common SharesSEC:0001171843-26-003802:0
19,000 shares0Common SharesSEC:0001171843-26-003804:0
19,000 shares0Common SharesSEC:0001171843-26-003805:0
6,392 shares0Common SharesSEC:0001171843-25-002829:0
5,784 shares0Common SharesSEC:0001171843-25-001997:0
6,339 shares0Common SharesSEC:0001171843-25-001217:0
41,666 shares@ US$1.92100.0% of flowCommon SharesSEC:0001171843-25-000867:0
25 of 65 declarations
About Edesa Biotech, Inc.
Edesa Biotech, Inc. is a company focused on developing treatments for inflammatory diseases and dermatological disorders. It is listed on NASDAQ under the ticker EDSA.